These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31534635)

  • 1. Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.
    Ohmoto A; Suzuki M; Takai E; Rokutan H; Fujiwara Y; Morizane C; Yanagihara K; Shibata T; Yachida S
    Oncotarget; 2019 Sep; 10(52):5494. PubMed ID: 31534635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells.
    Chen R; Li Y; Buttyan R; Dong X
    Oncotarget; 2018 Jul; 9(51):29842. PubMed ID: 30038724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.
    Kim S; Tiedt R; Loo A; Horn T; Delach S; Kovats S; Haas K; Engstler BS; Cao A; Pinzon-Ortiz M; Mulford I; Acker MG; Chopra R; Brain C; Tomaso ED; Sellers WR; Caponigro G
    Oncotarget; 2020 Apr; 11(14):1289. PubMed ID: 32292577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Calcium electroporation for treatment of sarcoma in preclinical studies.
    Szewczyk A; Gehl J; Daczewska M; Saczko J; Frandsen SK; Kulbacka J
    Oncotarget; 2019 Aug; 10(49):5118. PubMed ID: 31489120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.
    Ohmoto A; Suzuki M; Takai E; Rokutan H; Fujiwara Y; Morizane C; Yanagihara K; Shibata T; Yachida S
    Oncotarget; 2018 Apr; 9(30):21086-21099. PubMed ID: 29765522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma.
    Zhu J; Wang M; Yu Y; Qi H; Han K; Tang J; Zhang Z; Zeng Y; Cao B; Qiao C; Zhang H; Hou T; Mao X
    Oncotarget; 2019 Dec; 10(65):7010-7011. PubMed ID: 31857854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
    Chung S; Kijima K; Kudo A; Fujisawa Y; Harada Y; Taira A; Takamatsu N; Miyamoto T; Matsuo Y; Nakamura Y
    Oncotarget; 2020 Oct; 11(41):3749-3750. PubMed ID: 33110482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction:
    Mellai M; Cattaneo M; Storaci AM; Annovazzi L; Cassoni P; Melcarne A; De Blasio P; Schiffer D; Biunno I
    Oncotarget; 2018 Aug; 9(66):32731. PubMed ID: 30220979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.
    Hu J; Song C; Duan B; Zhang X; Li D; Zhu L; Gao H
    Oncotarget; 2018 Jul; 9(58):31311. PubMed ID: 30131857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.
    Khatri A; Gu JJ; McKernan CM; Xu X; Pendergast AM
    Oncotarget; 2019 Oct; 10(57):6045-6046. PubMed ID: 31666936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma.
    Pagès G
    Oncotarget; 2018 Nov; 9(87):35796. PubMed ID: 30515272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
    Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
    Oncotarget; 2018 Feb; 9(16):13101. PubMed ID: 29569656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.
    Bharadwaj U; Eckols TK; Xu X; Kasembeli MM; Chen Y; Adachi M; Song Y; Mo Q; Lai SY; Tweardy DJ
    Oncotarget; 2019 Feb; 10(16):1603. PubMed ID: 30899429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2018 Feb; 9(15):12534. PubMed ID: 29552331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment.
    Zhang H; Zhan C; Ke J; Xue Z; Zhang A; Xu K; Shen Z; Yu L; Chen L
    Oncotarget; 2018 Oct; 9(81):35285. PubMed ID: 30443297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
    Oncotarget; 2018 Oct; 9(79):35026. PubMed ID: 30405891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies.
    Zhang S; Jia Z; Yan Z; Yang J
    Oncotarget; 2018 Aug; 9(61):31937. PubMed ID: 30159134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
    Xie H; Li C; Dang Q; Chang LS; Li L
    Oncotarget; 2019 Jun; 10(39):3978. PubMed ID: 31231473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
    Li Y; Jia Y; Che Q; Zhou Q; Wang K; Wan XP
    Oncotarget; 2020 Feb; 11(7):755-757. PubMed ID: 32133049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.